| Section | Provisional content |
|---|---|
| Retrieval / citation status | **No tool-retrieved citable contexts were available in this run; all publication-specific claims below require manual verification against the seed papers before curation.** |
| Executive judgment | **Partially supported (provisional).** The seed evidence is consistent with biallelic or otherwise damaging **SYCE1** variants causing meiotic failure via synaptonemal-complex dysfunction, but confidence is limited because none of the cited papers were retrievable here for direct verification. |
| Evidence base (seed PMIDs with PubMed URLs) | **PMID:25062452** — https://pubmed.ncbi.nlm.nih.gov/25062452/ ; **PMID:32402064** — https://pubmed.ncbi.nlm.nih.gov/32402064/ ; **PMID:34718620** — https://pubmed.ncbi.nlm.nih.gov/34718620/ ; **PMID:35718780** — https://pubmed.ncbi.nlm.nih.gov/35718780/ |
| Clinical spectrum: 46,XX | Seed evidence supports **primary ovarian insufficiency / primary amenorrhea** in 46,XX individuals, including a familial case with a homozygous nonsense SYCE1 variant; specific endocrine values, ovarian imaging, and follicle depletion details were not available in this run. |
| Clinical spectrum: 46,XY | Seed evidence supports **non-obstructive azoospermia** with **pachytene-stage spermatogenic arrest** on H&E/IF in 46,XY individuals with SYCE1 CNVs; semen parameters beyond azoospermia, hormones, and biopsy-marker details were not retrievable here. |
| Variant / inheritance summary | Provisional model: **autosomal recessive / biallelic**. Seed evidence mentions a **homozygous nonsense variant c.613C>T**, additional damaging variants affecting SYCE1 interactions, and **SYCE1 CNVs**; exact zygosity/phasing, family counts, and ACMG classifications require manual verification. |
| Mechanistic chain | Provisional chain: **biallelic SYCE1 loss/damaging variant -> reduced or absent SYCE1 -> disrupted interaction with SYCP1 and/or C14ORF39/SIX6OS1 -> synaptonemal-complex central element assembly failure -> homologous chromosome synapsis failure -> pachytene arrest/checkpoint activation -> germ-cell depletion -> 46,XX POI/primary amenorrhea or 46,XY NOA/spermatogenic arrest**. Human support appears strongest for phenotype/arrest endpoints, with some intermediate steps likely relying on model or in vitro evidence. |
| Diagnostics / management implications | Provisional practice implications: include **SYCE1** on infertility/POI/NOA genetic panels with **CNV detection**; in 46,XY consider semen analysis, endocrine evaluation, and biopsy when indicated; in 46,XX assess ovarian reserve and POI biochemistry. Management likely follows standard care pathways: hormone replacement for POI as indicated, fertility counseling, donor-oocyte discussion for POI, and cautious consideration of micro-TESE/ICSI in NOA if any sperm retrieval is feasible. |
| Ontology suggestions | **HPO:** Primary ovarian insufficiency; Primary amenorrhea; Female infertility; Azoospermia; Non-obstructive azoospermia; Spermatogenic arrest; Hypergonadotropic hypogonadism. **GO:** Meiotic cell cycle; Homologous chromosome pairing; Synaptonemal complex assembly; Meiotic recombination; Germ cell apoptotic process. **CL:** Primary oocyte; Spermatocyte; Pachytene spermatocyte; Germ cell. **Treatment/action terms:** Genetic testing; Genetic counseling; Hormone replacement therapy; Fertility preservation; Oocyte cryopreservation; Micro-TESE; ICSI; PGT-M. |
| Knowledge gaps | Major gaps are due to retrieval failure: no verified full texts, no figure/table access, no confirmed endocrine data (e.g., FSH/AMH), incomplete histology details, uncertain CNV phasing/zygosity, and limited direct human evidence for checkpoint activation or apoptosis. No 2023-2024 studies could be prioritized in this environment. |
| Curator leads | Provisional updates to consider after verification: (1) annotate the mechanism as a **meiotic synaptonemal-complex central element assembly defect**; (2) capture the dual-sex phenotype of **46,XX POI/primary amenorrhea** and **46,XY NOA/pachytene arrest**; (3) note support for **loss-of-function and CNV** mechanisms; (4) add the partner-interaction mechanism involving **SYCP1** and **C14ORF39/SIX6OS1**. |


*Table: This table consolidates the requested curation elements for SYCE1-related gametogenic failure into a compact provisional report. It highlights the seed evidence, proposed mechanism, and major verification needs while clearly noting that no tool-retrieved citable contexts were available in this run.*